Revenue | ₹236.71Cr |
Net Profits | ₹23.27Cr |
Net Profit Margins | 9.83% |
Bliss GVS Pharma Ltd’s revenue jumped 4.89% since last year same period to ₹236.71Cr in the Q3 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -6.39% fall in its revenue since last 3-months.
Bliss GVS Pharma Ltd’s net profit fell -2.23% since last year same period to ₹23.27Cr in the Q3 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -14.61% fall in its net profits since last 3-months.
Bliss GVS Pharma Ltd’s net profit margin fell -6.78% since last year same period to 9.83% in the Q3 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -8.78% fall in its net profit margins since last 3-months.
The revenue for Bliss GVS Pharma Ltd in the Q3 results 2025 was ₹236.71Cr.
The net profit for Bliss GVS Pharma Ltd in the Q3 results 2025 was ₹23.27Cr.
The net profit margin for Bliss GVS Pharma Ltd in the Q3 results 2025 was 9.83%.
The revenue for Bliss GVS Pharma Ltd in the Q3 results 2024 was ₹225.68Cr.
The net profit for Bliss GVS Pharma Ltd in the Q3 results 2024 was ₹23.80Cr.
The net profit margin for Bliss GVS Pharma Ltd in the Q3 results 2024 was 10.55%.